Lier Chemical Co.,LTD.: history, ownership, mission, how it works & makes money

Founded in collaboration with the China Academy of Engineering Physics and the Russian Academy of Science in 1993, Lier Chemical Co., Ltd. (Shenzhen: 002258) has grown into a national agrochemical player operating seven production bases (Mianyang, Guang'an, Nantong, Yueyang, Jinshi, Hebi and Jingzhou) and producing over 40 technical materials and more than 100 formulations-from chloropyridines and amino acids to sulfonylureas and substituted ureas-backed by a national-level R&D center and ISO9000/14001/18000 certifications; in 2024 the company reported revenue of 7.31 billion yuan (down 6.87%) and net profit of 215.34 million yuan (down 64.34%), while as of October 15, 2025 it held a market capitalization of 10.05 billion yuan, an enterprise value of 13.65 billion yuan, 800.44 million shares outstanding, a trailing P/E of 21.83 and forward P/E of 21.66, insiders owning 2.76% and institutions 3.70%, and a debt-to-equity ratio of 0.40; the company reinvests heavily in innovation (about 10% of revenue, ~1 billion yuan in 2023), achieved a 15% greenhouse-gas reduction toward a 25% 2025 target, grew exports to over 30 countries with export sales up 20% to 5 billion yuan in 2023, and combines long-term global partnerships, diversified product lines, and certified manufacturing to drive revenues from herbicides, insecticides, fungicides and chemical intermediates while projecting a rebound in profitability in 2025.

Lier Chemical Co.,LTD. (002258.SZ): Intro

• Founded in 1993 as a high-tech enterprise jointly initiated by the China Academy of Engineering Physics (CAEP) and the Russian Academy of Science, focused on R&D, production and sales of efficient and safe pesticides.
• Listed on the main board of Shenzhen Stock Exchange in July 2008 (stock code: 002258), marking its transition to a publicly traded enterprise.
• Expanded manufacturing footprint to seven production bases across China: Mianyang, Guang'an, Nantong, Yueyang, Jinshi, Hebi and Jingzhou.
• Product portfolio growth from early specialty intermediates to a broad agrochemical catalogue covering over 40 technical materials and more than 100 formulations.

• Originating sponsors: China Academy of Engineering Physics (CAEP) and the Russian Academy of Science (initial joint initiative).
• Public shareholders: free-float retail and institutional investors following the 2008 listing; corporate governance subject to Shenzhen Stock Exchange rules.
• Management and board: professional executive management with a board overseeing strategy, compliance and large-capital decisions (board composition varies by annual report).

• Mission: develop and commercialize efficient, safe agrochemicals that boost crop yields while reducing environmental and human health risks.
• R&D emphasis: chloropyridines, amino acid derivatives, sulfonylureas, substituted ureas and other high-value intermediates and formulations.
• Strategy pillars: expand production capacity, diversify formulations, strengthen downstream formulation sales, and pursue international market penetration.

• Core chemical families: chloropyridines, amino acids, sulfonylureas, substituted ureas.
• Scale: over 40 technical materials and 100+ finished formulations servicing crop protection sectors.
• Production bases (7): Mianyang, Guang'an, Nantong, Yueyang, Jinshi, Hebi, Jingzhou - positioned to serve domestic and export demand.

• R&D-driven product development: in-house synthesis and formulation development to create proprietary technical materials and formulations.
• Manufacturing: multi-site production of technical materials and downstream formulation blending for direct customers and distributors.
• Sales channels: direct sales to agrochemical distributors, OEM/formulation contracts, exports, and branded formulation sales into the farmer/retailer channel.
• Value capture: margin from proprietary technical materials, scale-driven cost advantages in production, formulation value-add, and licensing/technology transfer in select cases.

• Recent performance (2024) shows revenue resilience but significant net profit contraction driven by margin pressure, cost factors and market headwinds.
• Capacity footprint across seven bases provides flexibility to shift production and optimize logistics to support recovery.
• Company projects a recovery in 2025 with anticipated net profit growth based on market improvement and strategic initiatives (product mix optimization, cost controls, expanded formulation sales).

• For investor-focused detail on ownership flows and buyer composition, see: Exploring Lier Chemical Co.,LTD. Investor Profile: Who's Buying and Why?

Lier Chemical Co.,LTD. (002258.SZ): History

• Listed entity: Shenzhen Stock Exchange, stock code 002258.
• Core product lines: pharmaceutical intermediates, pesticide intermediates, specialty monomers and custom synthesis.
• Growth drivers: R&D investment, strategic capacity expansions, and export market penetration.

Ownership Structure

• Public float dominated structure with 800.44 million shares outstanding.
• Insiders: ~2.76% - management and directors, providing alignment with investors.
• Institutions: ~3.70% - diversified external investors but no single dominant block.
• Leverage stance: conservative, debt-to-equity ~0.40 supporting stable operations and capex funding.

Mission

• Deliver high-purity specialty chemicals and intermediates to pharma and agro markets.
• Invest in sustainable manufacturing and R&D to improve product mix and margins.
• Reference: Mission Statement, Vision, & Core Values (2026) of Lier Chemical Co.,LTD.

How It Works & Makes Money

• Revenue model: sale of chemical intermediates and finished specialty chemicals to pharmaceutical, agrochemical and industrial customers (domestic and export).
• Value chain: in-house R&D → pilot scale → commercial production → direct sales and distribution partnerships.
• Margin drivers: product mix skewed toward higher-margin specialty/custom synthesis, scale efficiencies, and patent/know-how for niche chemistries.
• Capital deployment: reinvestment in capacity and R&D financed via operating cash flow and modest leverage (EV 13.65B yuan; conservative debt/equity).

Lier Chemical Co.,LTD. (002258.SZ): Ownership Structure

• R&D investment: ~10% of revenue; ≈1.0 billion yuan in 2023.
• Export performance: export sales rose 20% to 5.0 billion yuan in 2023.
• GHG reduction target: 25% by 2025; 15% reduction achieved in 2023.
• Customer satisfaction: 85% in 2023; target 90% by 2024.
• Employee development: training coverage target >70% annually; engagement target 80% in 2024.

• Promoter/Founders: 35% - strategic control and board influence.
• Institutional investors (incl. funds, insurers): 25% - stable, long-term stakes.
• Public/retail float: 40% - liquidity supporting market valuation and capital access.

Lier Chemical Co.,LTD. (002258.SZ): Mission and Values

• Seven production bases across China: Mianyang, Guang'an, Nantong, Yueyang, Jinshi, Hebi and Jingzhou - providing diversified regional manufacturing capacity, logistic flexibility and risk dispersion.
• Product portfolio spans chloropyridines, amino acids, sulfonylureas, substituted ureas and related intermediates - covering over 40 technical materials and more than 100 finished formulations for foliar, seed and soil applications.
• National-level R&D center: centralized research capability for synthetic chemistry, formulation development and regulatory compliance, enabling faster route optimization, new product introductions and intellectual property creation.
• Quality, environmental and safety systems: certified to ISO9001 (quality), ISO14001 (environmental management) and ISO45001/ISO18000 (occupational health & safety), supporting standardized production and international market access.
• Global reach: exports to 30+ countries and regions (including Europe) via distributors and trading partners; established long-term strategic cooperations with internationally known agricultural enterprises to support co-development and distribution.

• Technical materials manufacturing - high-margin specialty intermediates sold to formulators and OEMs, often via long-term supply contracts.
• Formulated products - finished crop protection formulations sold to domestic distributors, dealers and export partners under various commercial brands and contract arrangements.
• R&D and toll synthesis - paid development, custom synthesis and contract manufacturing for third parties leveraging the company's chemistry and plant capacity.
• Export and distribution partnerships - revenue from international sales through distributors and strategic partners, including co-marketing and licensing agreements with multinational agricultural firms.

• Scale and geographic spread of seven plants reduce single-site risk and improve supply continuity for large-volume intermediates.
• Diversified product mix (intermediates + formulations) balances cyclicality: intermediates sell to industrial customers while formulations capture downstream margin.
• Investment in R&D and a national R&D center accelerates new active ingredient routes and formulation optimization, shortening time-to-market and enabling higher-margin specialty products.
• International certifications and compliance frameworks facilitate entry into regulated export markets (e.g., EU), supporting premium pricing and repeat contracts.
• Strategic partnerships with global agricultural firms strengthen distribution, co-development opportunities and technology transfer - anchoring long-term revenue streams.

• Continuous expansion of formulation portfolio to move up the value chain and capture branded sales.
• Selective capacity increases at high-return production bases to meet demand for chloropyridines and specialty ureas.
• Enhancement of environmental controls and occupational safety to meet stricter export and domestic regulatory requirements.
• Strengthening international distributor network to increase overseas revenue share and reduce reliance on any single market.

Lier Chemical Co.,LTD. (002258.SZ): How It Works

• Primary product lines: herbicides, insecticides, fungicides and chemical intermediates (chloropyridines, amino acids, sulfonylureas, substituted ureas).
• Product breadth: >40 varieties of technical materials and >100 formulations sold under multiple dosage forms and crop segments.
• Quality & compliance: certified to ISO9000 quality system, ISO14001 environmental protection system and ISO18000 occupational safety health system.
• R&D capability: national-level R&D center supporting new molecule development, formulation optimization and registration dossiers for multiple markets.
• Global reach: exports to over 30 countries and regions, including Europe, via distributors and trading partners.

• Commercial sales of technical-grade active ingredients - produced in large batches and sold to formulators and trading houses.
• Sales of ready-to-use formulations - branded and private-label formulations to domestic distributors and agricultural dealers.
• Sales of chemical intermediates and specialty chemicals to industrial and agrochemical customers.
• Contract manufacturing and toll-processing for partners and international customers.
• R&D-driven product launches and registration-driven revenue expansion (new registrations widen addressable markets and margins).

• Economies of scale in synthesis of chloropyridines and substituted ureas reduce per-unit COGS for both technicals and formulations.
• R&D center accelerates new registrations and formulation improvements; newly registered products command premium pricing and extended patent/registration protection windows.
• Quality and safety certifications (ISO9000/14001/18000) facilitate export approvals and procurement by large agricultural enterprises.
• Strategic partnerships with international agricultural firms create stable off-take agreements and co-development opportunities that lower market-entry costs overseas.
• Export diversification (over 30 countries) mitigates single-market demand shocks and supports FX-denominated revenue streams.

• Long-term cooperative ties with internationally renowned agricultural enterprises provide stable sales pipelines, co-development pathways and enhanced distribution access.
• Use of international distributors and trading companies to penetrate regulated markets in Europe and Asia-Pacific while leveraging local registration expertise.
• Continuous product mix optimization - balancing higher-margin new formulations with steady-volume technical sales to maintain cash flow and fund R&D.

Lier Chemical Co.,LTD. (002258.SZ): How It Makes Money

• Flagship product line: glufosinate-ammonium (high-margin herbicide) and a portfolio of herbicides, insecticides and fungicides featuring complex heterocyclic chemistries.
• Production footprint: modern, large-scale plants enabling cost-efficient output and export compliance for developed markets.
• Sales channels: direct sales in China, distributor networks, and long-term export contracts to Europe & Latin America.
• Strategic relationships: stable partnerships with internationally renowned agricultural enterprises for R&D collaboration and market access.

• Lier Chemical is positioned as a leading Chinese agrochemical specialist with strong IP and scale advantages in glufosinate and other complex organic active ingredients.
• Export diversification (Europe, Latin America) reduces domestic cyclicality and supports higher-margin international sales; exports historically account for ~40% of revenue and are targeted to increase to ~45% by 2025.
• Operational scale and modern plants improve unit economics and regulatory compliance, aiding entry into higher-value markets.
• Management guidance and industry signals point to a rebound in 2025: company projects double-digit net profit growth driven by improved crop input demand, stabilized raw material costs, and higher-margin product mix (notably increased glufosinate sales and export growth).